Purchase Order 75F40123P00335
Award Date 8/31/23
Potential Completion Date 2/28/25
Potential Value $171K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order issued by the Department of Health and Human Services Food and Drug Administration (FDA) to The University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System, to provide 24 age-matched, Bordetella-free weanling baboons for use in Pertussis infection and vaccination studies. The contract has a potential value of $187,360.62 and was awarded on April 19, 2019 under full and open competition, with no set-aside...
- The Food and Drug Administration awarded a $911.7K firm fixed-price purchase order to The University of Texas MD Anderson Cancer Center in Houston, Texas on August 17, 2020, to conduct a five-year study evaluating the duration of pertussis immunity in baboons. Under this contract, MD Anderson will house and maintain up to 36 baboons (24 vaccinated and 12 convalescent) and collect biological samples while administering vaccines according to the statement of work requirements. The FDA's evaluation...
- This is a firm-fixed-price federal contract award valued at $425,645.08 from the Food and Drug Administration (FDA) to The University of Texas MD Anderson Cancer Center, a child entity of the University of Texas System. The contract is for an "IMMUNOGENICITY STUDY IN BABOONS FOLLOWING VACCINATION WITH EXPERIMENTAL ACELLULAR PERTUSSIS VACCINES" and does not have a set-aside designation. MD Anderson, a leading academic cancer research and treatment institution, has extensive experience...
- The Department of Health and Human Services Food and Drug Administration awarded a $143,340.00 firm fixed price purchase order to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to conduct a one-year study on baboons that have recovered from Bordetella pertussis (whooping cough) infection. The study will assess the duration of immune responses to B. pertussis in the research animals. This award is not associated with any larger contract...
- <p>The Food and Drug Administration awarded a purchase order to The University of Texas MD Anderson Cancer Center for a Bordetella-free baboon study with a ceiling value of $272,300.60, effective August 5, 2026. Work is performed in Houston, Texas, with an ultimate completion date of August 9, 2027. The contract uses firm fixed-price pricing with no set-aside category.</p>
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services Food and Drug Administration to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, in the amount of $162,459.55. The contract is for the supply of bordetella-free baboons, with a period of performance ending on July 29, 2021. The contract was awarded on July 30, 2020 and was not set aside for any specific business category. MD Anderson Cancer...
- This is a prime contract awarded by the U.S. government to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is for $6,155,674.00 and is a Definitive Contract with Cost No Fee pricing. The place of performance is Texas, USA. The contract is for biomedical (applied/exploratory) services and does not have a set-aside designation. MD Anderson Cancer Center, a comprehensive cancer treatment and research center, has received this prime...
- This is a federal contract award from the Office of Logistics and Acquisition Operations, a component of the National Institutes of Health (NIH), to The University of Texas M.D. Anderson Cancer Center (MD Anderson). The contract, with a ceiling value of $171,500.00, is for the acquisition, testing, transportation, and housing of non-human primate research colonies to support infectious disease and immunology studies at NIH facilities. The contract is a delivery order under a larger indefinite...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $70,000 firm fixed price delivery order to The University of Texas M.D. Anderson Cancer Center for per diem and testing costs associated with the NIAID Owl Monkey Colony through May 19, 2023. As the prime contractor, M.D. Anderson Cancer Center will provide care and testing for the monkeys through the completion date, with its parent organization the University of...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $123,000 firm fixed-price delivery order to The University of Texas MD Anderson Cancer Center for non-human primate acquisition, with an ultimate completion date of September 18, 2026. This delivery order, issued on September 19, 2025, represents a child contract under a larger vehicle and will be performed at NIAID's primary location in Bethesda, Maryland. The award was not designated under any small business...